ESCVS poster accepted

We are very pleased to accounce the acceptance of a study comparing donor blood transfusion rates and volumes with AvanCell(TM) Bio-Regenerative Fibrin System against current standard of care for a poster presentation at the 64th ESCVS, International Congress of the European Society of Cardiovascular and Endovascular Surgery in Istanbul, 26-29 March 2015.